The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $291.17

Today's change+6.04 +2.12%
Updated February 27 3:57 PM EST. Delayed by at least 15 minutes.
 

Biogen Inc

Nasdaq: BIIB
Last

(U.S.) $291.17

Today's change+6.04 +2.12%
Updated February 27 3:57 PM EST. Delayed by at least 15 minutes.

Biogen Inc up sharply

Biogen Inc closed up sharply Monday, rallying (U.S.)$6.04 or 2.12% to (U.S.)$291.17. Over the last five days, shares have gained 0.77%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 11.54% during the last year.

Key company metrics

  • Open(U.S.) $285.39
  • Previous close(U.S.) $285.13
  • High(U.S.) $291.25
  • Low(U.S.) $284.27
  • Bid / Ask(U.S.) $291.17 / (U.S.) $291.20
  • YTD % change+2.68%
  • Volume1,107,717
  • Average volume (10-day)1,801,250
  • Average volume (1-month)1,784,666
  • Average volume (3-month)1,782,318
  • 52-week range(U.S.) $223.02 to (U.S.) $333.65
  • Beta0.79
  • Trailing P/E17.22×
  • P/E 1 year forward13.59×
  • Forward PEG2.01×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $16.91
Updated February 27 3:57 PM EST. Delayed by at least 15 minutes.
S&P TSX0.07%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue2,8722,9562,8942,727
Total other revenue--------
Total revenue2,8722,9562,8942,727
Gross profit2,4942,5392,5242,414
Total cost of revenue379417370313
Total operating expense1,9861,5311,4341,348
Selling / general / administrative496463492497
Research & development534529473437
Depreciation / amortization1041009389
Interest expense (income), net operating--------
Unusual expense (income)463181112
Other operating expenses, total115-6--
Operating income8861,4251,4611,378
Interest income (expense), net non-operating-65-66-66-63
Gain (loss) on sale of assets--------
Other--------
Income before tax8381,3671,4021,326
Income after tax6481,0301,048969
Income tax, total190337354356
Net income6491,0331,050971
Total adjustments to net income--------
Net income before extra. items6491,0331,050971
Minority interest1312
Equity in affiliates0000
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items6491,0331,050971
Inc. avail. to common incl. extra. items6491,0331,050971
Diluted net income6491,0331,050971
Dilution adjustment--------
Diluted weighted average shares217219219219
Diluted EPS excluding extraordinary itemsvalue per share2.994.714.784.43
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share4.644.774.824.47